AU2001296013A1 - Pgd2 receptor antagonistic pharmaceutical compositions - Google Patents
Pgd2 receptor antagonistic pharmaceutical compositionsInfo
- Publication number
- AU2001296013A1 AU2001296013A1 AU2001296013A AU9601301A AU2001296013A1 AU 2001296013 A1 AU2001296013 A1 AU 2001296013A1 AU 2001296013 A AU2001296013 A AU 2001296013A AU 9601301 A AU9601301 A AU 9601301A AU 2001296013 A1 AU2001296013 A1 AU 2001296013A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- receptor antagonistic
- pgd2 receptor
- antagonistic pharmaceutical
- pgd2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000334383 | 2000-11-01 | ||
JP2000-334383 | 2000-11-01 | ||
PCT/JP2001/009435 WO2002036583A1 (en) | 2000-11-01 | 2001-10-26 | Pgd2 receptor antagonistic pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296013A1 true AU2001296013A1 (en) | 2002-05-15 |
Family
ID=18810309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296013A Abandoned AU2001296013A1 (en) | 2000-11-01 | 2001-10-26 | Pgd2 receptor antagonistic pharmaceutical compositions |
Country Status (5)
Country | Link |
---|---|
US (1) | US6933317B2 (en) |
EP (1) | EP1338594A4 (en) |
JP (1) | JPWO2002036583A1 (en) |
AU (1) | AU2001296013A1 (en) |
WO (1) | WO2002036583A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
US6980091B2 (en) * | 2002-12-10 | 2005-12-27 | Current Technologies, Llc | Power line communication system and method of operating the same |
US7308103B2 (en) * | 2003-05-08 | 2007-12-11 | Current Technologies, Llc | Power line communication device and method of using the same |
US20060291575A1 (en) * | 2003-07-03 | 2006-12-28 | Berkman William H | Power Line Communication System and Method |
US7321291B2 (en) * | 2004-10-26 | 2008-01-22 | Current Technologies, Llc | Power line communications system and method of operating the same |
CA2533747C (en) * | 2003-08-01 | 2012-11-13 | Chugai Seiyaku Kabushiki Kaisha | Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
DK1725553T3 (en) | 2004-03-11 | 2008-08-18 | Actelion Pharmaceuticals Ltd | Tetrahydropyridoindole derivatives |
US7265664B2 (en) * | 2005-04-04 | 2007-09-04 | Current Technologies, Llc | Power line communications system and method |
US7856032B2 (en) * | 2005-04-04 | 2010-12-21 | Current Technologies, Llc | Multi-function modem device |
US7259657B2 (en) * | 2005-06-21 | 2007-08-21 | Current Technologies, Llc | Multi-subnet power line communications system and method |
US20080012724A1 (en) * | 2006-01-30 | 2008-01-17 | Corcoran Kevin F | Power line communications module and method |
US7852207B2 (en) * | 2006-02-14 | 2010-12-14 | Current Technologies, Llc | Method for establishing power line communication link |
US7859646B2 (en) * | 2007-01-24 | 2010-12-28 | Adelphi University | Interferometric method for improving the resolution of a lithographic system |
WO2009043015A1 (en) * | 2007-09-27 | 2009-04-02 | The Trustees Of The University Of Pennsylvania | Tetranor pgdm: a biomarker of pgd2 synthesis in vivo |
US20110018704A1 (en) * | 2009-07-24 | 2011-01-27 | Burrows Zachary M | System, Device and Method for Providing Power Line Communications |
US20150065343A1 (en) | 2012-04-02 | 2015-03-05 | Basf Se | Acrylamide compounds for combating invertebrate pests |
BR112014027133A2 (en) | 2012-05-09 | 2017-06-27 | Basf Se | compound, agricultural or veterinary composition, method for controlling invertebrate pests, plant propagating material and method for treating or protecting an animal. |
JP6518692B2 (en) | 2014-04-17 | 2019-05-22 | ノバルティス アーゲー | Polycyclic HERG Activator |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4037941A1 (en) | 1990-11-23 | 1992-05-27 | Schering Ag | CYCLOPENTANETHER DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE |
DE4225488A1 (en) | 1992-07-30 | 1994-02-03 | Schering Ag | New bi:cyclooctane carbacyclin analogues - useful as thromboxane A2 and prostaglandin H2 antagonists |
EP0837052B1 (en) | 1995-06-21 | 2006-08-23 | Shionogi & Co., Ltd. | Bicyclic amino derivatives and pgd 2 antagonist containing the same |
AU5409698A (en) | 1996-12-12 | 1998-07-03 | Shionogi & Co., Ltd. | Fused heterocyclic benzenecarboxylic acid amide derivatives and pgd2 antagonists containing the same |
ID22753A (en) | 1996-12-13 | 1999-12-09 | Shionogi & Co | BENZOTIOFENCARCOXAMIDE CHARACTERS AND PGD2 ANTAGONISTS CONTAINING BENZOTIOFENCARCOX CARBOXAMIDE DISTRIBUTION |
WO1999015502A1 (en) | 1997-09-19 | 1999-04-01 | Shionogi & Co., Ltd. | Compounds having [2.2.1]bicyclo skeleton |
ATE295183T1 (en) * | 1998-06-03 | 2005-05-15 | Shionogi & Co | AGENTS FOR RELIEVING ITCH CONTAINING PGD2 ANTAGONISTS |
JPWO2001094309A1 (en) | 2000-06-02 | 2004-02-05 | 塩野義製薬株式会社 | PGD2 / TXA2 receptor antagonist pharmaceutical composition |
-
2001
- 2001-10-26 US US10/399,605 patent/US6933317B2/en not_active Expired - Fee Related
- 2001-10-26 EP EP01976842A patent/EP1338594A4/en not_active Withdrawn
- 2001-10-26 WO PCT/JP2001/009435 patent/WO2002036583A1/en not_active Application Discontinuation
- 2001-10-26 JP JP2002539342A patent/JPWO2002036583A1/en not_active Withdrawn
- 2001-10-26 AU AU2001296013A patent/AU2001296013A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040054003A1 (en) | 2004-03-18 |
EP1338594A1 (en) | 2003-08-27 |
EP1338594A4 (en) | 2004-06-16 |
WO2002036583A1 (en) | 2002-05-10 |
JPWO2002036583A1 (en) | 2004-03-11 |
US6933317B2 (en) | 2005-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001296013A1 (en) | Pgd2 receptor antagonistic pharmaceutical compositions | |
AU781269C (en) | Pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2001228665A1 (en) | Toll-like receptor | |
AU2001250205A1 (en) | Prostaglandin d2 receptor antagonists | |
AUPR769501A0 (en) | Cytokine receptor 1 | |
AU2002337803A1 (en) | Sustained release pharmaceutical compositions | |
AUPQ441699A0 (en) | Pour-on formulations | |
AU2001273032A1 (en) | Cytokine receptor zcytor17 | |
AU3556400A (en) | Pharmaceutical compositions | |
AUPR602501A0 (en) | Sustained release pharmaceutical composition | |
AU2001264657A1 (en) | Crf receptor antagonists | |
AU2001264264A1 (en) | Sustained release compositions | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
AU2001260627A1 (en) | Drug composition antagonistic to both pgd2/txa2 receptors | |
AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
AU2001248772A1 (en) | Sustained release drug compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU6460400A (en) | Pharmaceutical compositions | |
AU2002226048A1 (en) | Urotensin-ii receptor antagonists | |
AU2002239506A1 (en) | Urotensin-ii receptor antagonists | |
AU6460200A (en) | Pharmaceutical compositions | |
AU2001263288A1 (en) | Crf receptor antagonists |